Cargando…

Epigenetic markers in circulating cell‐free DNA as prognostic markers for survival of castration‐resistant prostate cancer patients

BACKGROUND: : Noninvasive biomarkers to guide personalized treatment for castration‐resistant prostate cancer (CRPC) are needed. In this study, we analyzed hypermethylation patterns of two genes (GSTP1 and APC) in plasma cell‐free DNA (cfDNA) of CRPC patients. The aim of this study was to analyze th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hendriks, Rianne J., Dijkstra, Siebren, Smit, Frank P., Vandersmissen, Johan, Van de Voorde, Hendrik, Mulders, Peter F. A., van Oort, Inge M., Van Criekinge, Wim, Schalken, Jack A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838798/ https://www.ncbi.nlm.nih.gov/pubmed/29330943 http://dx.doi.org/10.1002/pros.23477

Ejemplares similares

Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide
por: Benoist, Guillemette E., et al.
Publicado: (2016)

Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration‐resistant prostate cancer undergoing first‐line abiraterone acetate and prednisone treatment
por: Boerrigter, Emmy, et al.
Publicado: (2021)

Cross-Resistance between Platinum-Based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate Cancer
por: Slootbeek, Peter H. J., et al.
Publicado: (2023)

Clinically significant Prostate Cancer diagnosed using a urinary molecular biomarker-based risk score: two case reports
por: Minnee, Pieter, et al.
Publicado: (2019)

Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men
por: Hendriks, Rianne J., et al.
Publicado: (2021)

RNA Biomarkers as a Response Measure for Survival in Patients with Metastatic Castration-Resistant Prostate Cancer
por: Boerrigter, Emmy, et al.
Publicado: (2021)

Personalized Management in Low-Risk Prostate Cancer: The Role of Biomarkers
por: Dijkstra, Siebren, et al.
Publicado: (2012)

Enzalutamide: targeting the androgen signalling pathway in metastatic castration‐resistant prostate cancer
por: Schalken, Jack, et al.
Publicado: (2015)

Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer
por: Groen, Levi, et al.
Publicado: (2023)

Discovery of DNA methylation markers in cervical cancer using relaxation ranking
por: Ongenaert, Maté, et al.
Publicado: (2008)

Intratumoral steroidogenesis in castration-resistant prostate cancer: a target for therapy
por: Armandari, Inna, et al.
Publicado: (2014)

The effect of chemotherapy on the exposure–response relation of abiraterone in metastatic castration‐resistant prostate cancer
por: Boerrigter, Emmy, et al.
Publicado: (2021)

Single cell epigenetic visualization assay
por: Kint, Sam, et al.
Publicado: (2021)

Technical considerations in PCR-based assay design for diagnostic DNA methylation cancer biomarkers
por: Massen, Maartje, et al.
Publicado: (2022)

Impact of DNA damage repair defects and aggressive variant features on response to carboplatin‐based chemotherapy in metastatic castration‐resistant prostate cancer
por: Slootbeek, Peter H. J., et al.
Publicado: (2020)

Value of PCA3 to Predict Biopsy Outcome and Its Potential Role in Selecting Patients for Multiparametric MRI
por: Leyten, Gisele H. J. M., et al.
Publicado: (2013)

Evaluation of chemical castration with calcium chloride versus surgical castration in donkeys: testosterone as an endpoint marker
por: Ibrahim, Ahmed, et al.
Publicado: (2016)

Spectral Prediction Features as a Solution for the Search Space Size Problem in Proteogenomics
por: Verbruggen, Steven, et al.
Publicado: (2021)

The Search for a Volatile Human Specific Marker in the Decomposition Process
por: Rosier, E., et al.
Publicado: (2015)

Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancer
por: Rönnau, C. G. H., et al.
Publicado: (2021)

Erratum to: Evaluation of chemical castration with calcium chloride versus surgical castration in donkeys: testosterone as an endpoint marker
por: Ibrahim, Ahmed, et al.
Publicado: (2016)

A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection
por: Van Neste, Leander, et al.
Publicado: (2012)

Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
por: van der Doelen, Maarten J., et al.
Publicado: (2021)

Label retention and stem cell marker expression in the developing and adult prostate identifies basal and luminal epithelial stem cell subpopulations
por: Ceder, Jens Adam, et al.
Publicado: (2017)

Hydroxymethylation of DNA: an epigenetic marker
por: Richa, Rajneesh, et al.
Publicado: (2014)

EPIGENETICS MARKERS OF AGING AND EXPOSURES
por: Murabito, Joanne
Publicado: (2019)

Epigenetic Markers Associated with Schistosomiasis
por: Gomes Assenço, R. A., et al.
Publicado: (2021)

Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer
por: Nagaya, Naoya, et al.
Publicado: (2020)

Molecular Phenotyping of AR Signaling for Predicting Targeted Therapy in Castration Resistant Prostate Cancer
por: Hamid, Agus Rizal A. H., et al.
Publicado: (2021)

Circulating microRNAs as Diagnostic Markers in Primary Aldosteronism
por: MacKenzie, Scott M., et al.
Publicado: (2021)

Neonatal Antibiotic Treatment Is Associated With an Altered Circulating Immune Marker Profile at 1 Year of Age
por: Oosterloo, Berthe C., et al.
Publicado: (2020)

Circulating Markers of Angiogenesis and Endotheliopathy in COVID-19
por: Meizlish, Matthew L., et al.
Publicado: (2020)

Combination of circulating tumor cell enumeration and tumor marker detection in predicting prognosis and treatment effect in metastatic castration-resistant prostate cancer
por: Chang, Kun, et al.
Publicado: (2015)

Epigenetic Markers for Bladder Cancer in Urine
por: Kim, Wun-Jae, et al.
Publicado: (2007)

Epigenetic Markers and Response to Chemotherapy in Cancer
por: Strathdee, Gordon
Publicado: (2007)

Brain-specific epigenetic markers of schizophrenia
por: Wockner, L F, et al.
Publicado: (2015)

Genetic and Epigenetic Markers of Lithium Response
por: Pisanu, Claudia, et al.
Publicado: (2022)

Localization of Epigenetic Markers in Leishmania Chromatin
por: McDonald, Jacquelyn R., et al.
Publicado: (2022)

Circulating markers of angiogenesis and endotheliopathy in COVID-19
por: Pine, Alexander B., et al.
Publicado: (2020)

Yeast Two-Hybrid: State of the Art
por: Van Criekinge, Wim, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_maolpjccqjn9q5t67216062e5h